Development and Validation of Data-Driven Estimates of Recurrence Risk and Treatment Benefit in Early Breast Cancer. Sparano JA. J Clin Oncol 2024 Dec 12:JCO2402452. doi: 10.1200/JCO-24-02452.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Sparano JA. Development and Validation of Data-Driven Estimates of Recurrence Risk and Treatment Benefit in Early Breast Cancer. J Clin Oncol 2024 Dec 12:JCO2402452. doi: 10.1200/JCO-24-02452.
PMID: 39666933